[Effects and actions of EM (erythromycin), CAM (clarithromycin), and JM (josamycin) on IL-4 and IL-5 production by monocytes].
Tei
A
A
Mineshita
M
M
Haruta
Y
Y
Ishioka
S
S
Yamakido
M
M
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology*; D004917:Erythromycin / Q000494:pharmacology*; D005260:Female; D006801:Humans; D015847:Interleukin-4 / Q000096:biosynthesis*; D015848:Interleukin-5 / Q000096:biosynthesis*; D015570:Josamycin / Q000494:pharmacology*; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000276:immunology*
D000900:Anti-Bacterial Agents; D015848:Interleukin-5; D015847:Interleukin-4; D004917:Erythromycin; D017291:Clarithromycin; D015570:Josamycin